Skip to content
Search

Latest Stories

 Aspire Pharma acquires Morningside Pharmaceuticals and its subsidiaries

Morningside Pharmaceuticals, a leading pharmaceutical group founded by an Asian businessman and his wife, has been acquired by Hampshire-based Aspire Pharma.

Morningside Pharmaceuticals (Loughborough), Morningside Healthcare (Leicester) and Morningside Healthcare (India) were all sold to Aspire Pharma Limited on Monday (October 3).


Aspire is present in the generics, speciality generics, branded medicines, and medical device sectors.

Details of the financial agreement were not disclosed by either party.

“This is a transformative opportunity for both companies to expand and enhance our position as a result of both companies’ highly complementary product portfolios,” said Richard Condon, chief executive officer of Aspire Pharma.

“The combination will create one of the largest and fastest growing UK pharma companies,” he added.

Morningside chief executive officer, Tim Brady, said: “Aspire’s acquisition of Morningside is validation of the long-term growth plan that the shareholders and management of Morningside Pharmaceuticals and Morningside Healthcare have developed over the past 30 years.”

The organisations involved will continue to operate as standalone businesses until further integration and transition announcements are made, according to a statement.

Nik Kotecha and his wife Moni, in the early 1990s, established Morningside Pharmaceuticals, which is a key manufacturer and supplier of generic and branded medicines to the NHS.

The business has a portfolio of more than 240 licensed medicines in the UK and EU and exports to more than 120 countries.

More For You

NHS England to halve workforce to cut costs

“We are entering a period of critical transformation for our NHS," says Wes Streeting.

Getty Images

NHS England to halve workforce in biggest reshaping in over a decade

NHS England and the Department of Health and Social Care (DHSC) are set for significant downsizing as they strengthen collaboration under the 10-Year Health Plan to build a future-fit health service.

As part of this transformation, the NHSE workforce is expected to be reduced by up to 50% to cut costs and eliminate duplication with DHSC officials.

Keep ReadingShow less
Discrimination: Asian and Black patients report lack of trust in primary care providers

Ethnic minority groups had worse experiences in their communication with their GP practice and felt taken less seriously

Getty Images

Survey reveals alarming rates of ethnic discrimination in NHS primary care

A recent survey by the NHS Race and Health Observatory has highlighted a worrying lack of trust in NHS primary care services among Black, Asian, and ethnic minority patients, who reported experiencing “racial or ethnic discrimination.”

Out of 2,680 survey respondents, only 55% reported trusting primary care providers to meet their health needs most or all of the time

Keep ReadingShow less
Swizzels’ Easter range, including Squashies Drumchick and Sweet Shop Favourite tubs

PDA members will get the chance to vote from this week

Pic credit: iStock

PDA to inform its members to vote “no” in Royal College of Pharmacy proposals

A vote to create a potential Royal College of Pharmacy needs to be called off as the current proposals would lead to “irreversible change to the identity and purpose” of the sector’s professional leadership body, according to the Pharmacy Defence Association (PDA).

From March 13th to March 24th, The Royal Pharmaceutical Society’s members will take part in a Special Resolution Vote (SRV) which seeks to amend the Society’s Royal Charter to facilitate its transition to a Royal College and registered charity.

Keep ReadingShow less
Walgreens Boots Alliance acquired by Sycamore in deal

Walgreens Boots Alliancehas entered into “a definitive agreement” to be acquired by Sycamore Partners

Gettyimages

Walgreens Boots Alliance acquired by Sycamore in £18.3 billion deal

Walgreens Boots Alliance(WBA) has entered into “a definitive agreement” to be acquired by Sycamore Partners, a private equity firm specializing in retail, consumer and distribution-related investments.

“The total value of the transaction represents up to $23.7 billion (£18.3 billion),” the company announced late last night (6).

Keep ReadingShow less
Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less